Abstract
N-triethyl chitosan (TEC) has recently been proven to be an efficient polymer for improving transport of hydrophilic drugs. Thus, in order to evaluate its gene delivery efficiency, TEC is assembled with Enhanced Green fluorescence protein plasmid DNA (pEGFP) at different polymer to plasmid (N/P) ratios to form TEC/pEGFP nanoparticles. Photon correlation spectroscopy is used to evaluate nanoparticles size and zeta potential. The transfection efficiency and cytotoxicity in gene delivery to AsPC-1 cells (human pancreatic cancer cells) are evaluated via fluorescence microscopy, flow cytometry and MTT assay. Also parameters such as cancer cells’ mean fluorescence intensity (MFI) and cell size changes after transfection are assayed. The results indicate that the incorporation of pEGFP in TEC can form charged nanoparticles at N/P ratios from 10 to 40. Increasing the N/P ratio increases transfection efficiency, MFI, cell size and cytotoxicity. At N/P ratio of 10, transfection increased up to 11.12 fold with the least cytotoxicity. Considering that mathematical models can be used to understand and predict consequences associated with nanomedicine, the relation between TEC /pDNA nanoparticles charge ratio, cell transfection and toxicity was evaluated for the first time with interpolation polynomial method.
Keywords: N-triethyl chitosan, nanoparticles, AsPC-1 cells, gene delivery, transfection, cytotoxicity, mathematical models.
Drug Delivery Letters
Title:Evaluating Gene Delivery Using N-triethyl Chitosan Nanoparticles to AsPC-1 Cells and Predicting the Relation between Transfection, Cytotoxicity and Charge Ratio of Nanoparticles Via Mathematical Models
Volume: 3 Issue: 1
Author(s): S. Safari, F.A. Dorkoosh, M. Soleimani, M. H. Zarrintan, H. Akbari, B. Larijani and M. Rafiee Tehrani
Affiliation:
Keywords: N-triethyl chitosan, nanoparticles, AsPC-1 cells, gene delivery, transfection, cytotoxicity, mathematical models.
Abstract: N-triethyl chitosan (TEC) has recently been proven to be an efficient polymer for improving transport of hydrophilic drugs. Thus, in order to evaluate its gene delivery efficiency, TEC is assembled with Enhanced Green fluorescence protein plasmid DNA (pEGFP) at different polymer to plasmid (N/P) ratios to form TEC/pEGFP nanoparticles. Photon correlation spectroscopy is used to evaluate nanoparticles size and zeta potential. The transfection efficiency and cytotoxicity in gene delivery to AsPC-1 cells (human pancreatic cancer cells) are evaluated via fluorescence microscopy, flow cytometry and MTT assay. Also parameters such as cancer cells’ mean fluorescence intensity (MFI) and cell size changes after transfection are assayed. The results indicate that the incorporation of pEGFP in TEC can form charged nanoparticles at N/P ratios from 10 to 40. Increasing the N/P ratio increases transfection efficiency, MFI, cell size and cytotoxicity. At N/P ratio of 10, transfection increased up to 11.12 fold with the least cytotoxicity. Considering that mathematical models can be used to understand and predict consequences associated with nanomedicine, the relation between TEC /pDNA nanoparticles charge ratio, cell transfection and toxicity was evaluated for the first time with interpolation polynomial method.
Export Options
About this article
Cite this article as:
Safari S., Dorkoosh F.A., Soleimani M., Zarrintan M. H., Akbari H., Larijani B. and Tehrani M. Rafiee, Evaluating Gene Delivery Using N-triethyl Chitosan Nanoparticles to AsPC-1 Cells and Predicting the Relation between Transfection, Cytotoxicity and Charge Ratio of Nanoparticles Via Mathematical Models, Drug Delivery Letters 2013; 3 (1) . https://dx.doi.org/10.2174/2210304x11303010002
DOI https://dx.doi.org/10.2174/2210304x11303010002 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Energetics of Quadruplex-Drug Recognition in Anticancer Therapy
Current Cancer Drug Targets MutS Homologues hMSH4 and hMSH5: Genetic Variations, Functions, and Implications in Human Diseases
Current Genomics 1,2,4-Triazine Analogs as Novel Class of Therapeutic Agents
Mini-Reviews in Medicinal Chemistry Editorial [Hot Topic: Diagnostic and Therapeutic Optical Imaging Techniques]
Current Medical Imaging Cisplatin Resistance and Transcription Factors
Current Medicinal Chemistry - Anti-Cancer Agents Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges
Current Cancer Drug Targets Longevity Pathways: HSF1 and FoxO Pathways, a New Therapeutic Target to Prevent Age-Related Diseases
Current Aging Science Neonatal Fc Receptor and its Role in the Absorption, Distribution, Metabolism and Excretion of Immunoglobulin G-Based Biotherapeutics
Current Drug Metabolism Small Molecule Integrin Antagonists in Cancer Therapy
Mini-Reviews in Medicinal Chemistry Synthesis of Methotrexate Loaded Chitosan Nanoparticles and in vitro Evaluation of the Potential in Treatment of Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry Synthetic Peptide Drugs for Targeting Skin Cancer: Malignant Melanoma and Melanotic Lesions
Current Medicinal Chemistry Technetium-99m-based Radiopharmaceuticals in Sentinel Lymph Node Biopsy: Gynecologic Oncology Perspective
Current Pharmaceutical Design Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents
Anti-Cancer Agents in Medicinal Chemistry Chemoprevention of Skin Carcinomas in High-Risk Transplant Recipients
Current Medicinal Chemistry Dietary Phytochemicals in Chemoprevention of Cancer
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Intracellular Delivery of Potential Therapeutic Genes: Prospects in Cancer Gene Therapy
Current Gene Therapy The Finely Regulating Well-defined Functional Polymeric Nanocarriers for Anti-tumor Immunotherapy
Mini-Reviews in Medicinal Chemistry The Yin and Yang of Antiviral Innate Immunity in Central Nervous System
Current Pharmaceutical Design Quassinoids: From Traditional Drugs to New Cancer Therapeutics
Current Medicinal Chemistry Blood-Brain-Barrier Models for the Investigation of Transporter- and Receptor-Mediated Amyloid-β Clearance in Alzheimers Disease
Current Alzheimer Research